Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 13, 2014, Pages 4892-4897

  Caizzi, Livia ^a,b,c   Ferrero, Giulio ^a   Cutrupi, Santina ^a   Cordero, Francesca ^a   Ballaré, Cecilia ^c,d   Miano, Valentina ^a   Reineri, Stefania ^b   Ricci, Laura ^b   Friard, Olivier ^a   Testori, Alessandro ^a   Corà, Davide ^a,e   Caselle, Michele ^a   Di Croce, Luciano ^c,d,f   De Bortoli, Michele ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Bioindustry Park Silvano Fumero   (Italy)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITY OF TURIN   (Italy)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Chromatin binding; Enhancer; Epigenetics; Pioneer factors; Transcriptome

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; MESSENGER RNA; SMALL INTERFERING RNA; UNTRANSLATED RNA;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL MATURATION; CHROMATIN; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; GENETIC LINKAGE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING;

CHROMATIN BINDING; ENHANCER; EPIGENETICS; PIONEER FACTORS; TRANSCRIPTOME;

BINDING SITES; BREAST NEOPLASMS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE ONTOLOGY; GENOME, HUMAN; HUMANS; LIGANDS; MCF-7 CELLS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 84897537555     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315445111     Document Type: Article

References (39)

1. Al Saleh S, Al Mulla F, Luqmani YA (2011) Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells. PLoS ONE 6(6):e20610.
2. Maggi A (2011) Liganded and unliganded activation of estrogen receptor and hormone replacement therapies. Biochim Biophys Acta 1812(8):1054-1060.
3. Cvoro A, et al. (2006) Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell 21(4):555-564.
4. Dhasarathy A, Kajita M, Wade PA (2007) The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol 21(12):2907-2918.
5. Cardamone MD, et al. (2009) ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells. Proc Natl Acad Sci USA 106(18):7420-7425.
6. Miller TW, et al. (2011) ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Cancer Discov 1(4):338-351.
7. He HH, et al. (2012) Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res 22(6):1015-1025.
8. Aguilar H, et al. (2010) Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. Oncogene 29(45):6071-6083.
9. Hewitt SC, et al. (2012) Research resource: Whole-genome estrogen receptor α binding in mouse uterine tissue revealed by ChIP-seq. Mol Endocrinol 26(5):887-898.
10. Carroll JS, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38(11):1289-1297.
11. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43(1): 27-33.
12. Cicatiello L, et al. (2010) Estrogen receptor alpha controls a gene network in luminallike breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol 176(5):2113-2130.
13. Kwon Y-S, et al. (2007) Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc Natl Acad Sci USA 104(12):4852-4857.
14. Neve RM, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6):515-527.
15. Welboren W-J, et al. (2009) ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J 28(10):1418-1428.
16. Madak-Erdogan Z, Lupien M, Stossi F, Brown M, Katzenellenbogen BS (2011) Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol Cell Biol 31(1):226-236.
17. Ross-Innes CS, et al. (2010) Cooperative interaction between retinoic acid receptoralpha and estrogen receptor in breast cancer. Genes Dev 24(2):171-182.
18. McLean CY, et al. (2010) GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28(5):495-501.
19. Yu G, et al. (2010) GOSemSim: An R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26(7):976-978.
20. Tan SK, et al. (2011) AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J 30(13):2569-2581
21. corrected in EMBO J (2011), 30(13):2750.
22. Testori A, et al. (2012) The role of transposable elements in shaping the combinatorial interaction of transcription factors. BMC Genomics 13:400.
23. Joseph R, et al. (2010) Integrative model of genomic factors for determining binding site selection by estrogen receptor-α. Mol Syst Biol 6:456.
24. Ceschin DG, et al. (2011) Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin. Genes Dev 25(11):1132-1146.
25. Ross-Innes CS, et al. (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481(7381):389-393.
26. Laganière J, Deblois G, Giguère V (2005) Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells. Mol Endocrinol 19(6):1584-1592.
27. Hah N, et al. (2011) A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145(4):622-634.
28. Subramanian A, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
29. Orso F, et al. (2004) Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5?-untranslated region. Biochem J 377(Pt 2):429-438.
30. Magnani L, Lupien M (2014) Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling. Mol Cell Endocrinol 382(1):633-641.
31. Garcia-Bassets I, Wang D (2012) Cistrome plasticity and mechanisms of cistrome reprogramming. Cell Cycle 11(17):3199-3210.
32. Green KA, Carroll JS (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer 7(9):713-722.
33. Hewitt SC, Harrell JC, Korach KS (2005) Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67:285-308.
34. Zhao Y, et al. (2006) Identification of a basic helix-loop-helix transcription factor expressed in mammary gland alveolar cells and required for maintenance of the differentiated state. Mol Endocrinol 20(9):2187-2198.
35. Lupien M, et al. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132(6):958-970.
36. Ballaré C, et al. (2013) Nucleosome-driven transcription factor binding and gene regulation. Mol Cell 49(1):67-79.
37. McPherson LA, Baichwal VR, Weigel RJ (1997) Identification of ERF-1 as a member of the AP2 transcription factor family. Proc Natl Acad Sci USA 94(9):4342-4347.
38. Strutt H, Paro R (1999) Mapping DNA target sites of chromatin proteins in vivo by formaldehyde crosslinking. Methods Mol Biol 119:455-467.
39. Vicent GP, et al. (2011) Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. Genes Dev 25(8):845-862.